Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
for
Asthma
Location: Research Triangle Park NC
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Sex: All
Age: 18 - 60
Code: NCT02327897
Recruiting
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
for
Soft Tissue Lesion
Location: Durham NC, Anderson SC, Morgantown WV, Wynnewood PA,
Sponsor: Galvanize Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05851430
Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Winston-Salem NC, Charlotte NC, Nashville TN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06158854
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Durham NC, Cary NC, Raleigh NC, Roanoke VA, Salem VA,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase3, Recruiting
Active & Responsive
Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
for
Nontuberculous Mycobacterial Pulmonary Infection,
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 0 - 70+
Code: NCT06155747
Recruiting
Repurposing Tilmanocept for Cardiac Sarcoidosis
for
Cardiac Sarcoidosis
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT07159074
Phase2, Recruiting
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for
Symptomatic Genetic Dilated Cardiomyopathy
Location: Durham NC, Washington D.C. DC, Columbus OH,
Sponsor: Kardigan, Inc.
Sex: All
Age: 18+
Code: NCT07210723
Phase2, Phase3, Recruiting
Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma
for
Severe Asthma
Location: Durham NC
Sponsor: Bastiaan Driehuys
Sex: All
Age: 18 - 65
Code: NCT07139899
Recruiting
Timing of Physician Rounds for Antepartum Patients
for
Physician Rounds, Communication
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18+
Code: NCT07215507
Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
for
Abdominal Aortic Aneurysm,
Location: Winston-Salem NC, Charlottesville VA,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 20+
Code: NCT05378347
Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Sex: All
Age: 0 - 70+
Code: NCT01500447
Recruiting
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
for
Cancer Weight Loss
Location: Durham NC, Charlottesville VA, Atlanta GA, New York NY,
Sponsor: Endevica Bio
Sex: All
Age: 18+
Code: NCT06937177
Phase2, Recruiting
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
for
Atrial Fibrillation
Location: Durham NC, Camden NJ, New York NY, London, Hamilton,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07217067
Phase2, Recruiting
Ventripoint Single Ventricle Study
for
Congenital Heart Disease, Single-ventricle
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT05262907
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.